Ann Hynes
Stock Analyst at Mizuho Securities
(4.63)
# 868
Out of 4,509 analysts
1108
Total ratings
59.1%
Success rate
8.6%
Average return
Main Sectors:
Stocks Rated by Ann Hynes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACHC Acadia Healthcare Company | Maintained: Hold | $27 → $31 | $31.28 | -0.90% | 46 | Jul 13, 2026 | |
| CRL Charles River Laboratories International | Maintained: Hold | $192 → $230 | $233.41 | -1.46% | 14 | Jul 13, 2026 | |
| CVS CVS Health | Maintained: Buy | $115 → $120 | $104.15 | +15.22% | 74 | Jul 13, 2026 | |
| MOH Molina Healthcare | Maintained: Buy | $215 → $255 | $233.31 | +9.30% | 36 | Jul 13, 2026 | |
| UNH UnitedHealth Group | Maintained: Buy | $460 → $470 | $424.62 | +10.69% | 56 | Jul 13, 2026 | |
| IQV IQVIA Holdings | Maintained: Buy | $215 → $230 | $207.85 | +10.66% | 52 | Jul 13, 2026 | |
| MEDP Medpace Holdings | Maintained: Buy | $495 → $586 | $538.23 | +8.88% | 12 | Jul 13, 2026 | |
| ICLR ICON Public Limited Company | Maintained: Buy | $180 → $190 | $167.72 | +13.28% | 53 | Jun 26, 2026 | |
| CNC Centene | Maintained: Hold | $58 → $63 | $67.35 | -6.46% | 37 | Jun 8, 2026 | |
| CI The Cigna Group | Maintained: Buy | $330 → $340 | $293.46 | +15.86% | 38 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $335 → $390 | $392.22 | -0.57% | 46 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $435 → $465 | $416.23 | +11.72% | 45 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $11 → $13 | $17.76 | -26.80% | 14 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $18 → $24 | $26.27 | -8.64% | 43 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 → $30 | $31.55 | -4.91% | 9 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $52 → $61 | $71.43 | -14.60% | 19 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $267 → $230 | $155.57 | +47.84% | 61 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $235 → $265 | $204.25 | +29.74% | 52 | Mar 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 → $17 | $16.40 | +3.66% | 16 | Mar 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $540 → $585 | $406.59 | +43.88% | 62 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $320 | $276.81 | +15.60% | 60 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $235 | $207.44 | +13.29% | 63 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $134 | $110.16 | +21.64% | 41 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $12 | $10.08 | +19.05% | 7 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $303.44 | n/a | 38 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $805.96 | n/a | 52 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $110 | $235.80 | n/a | 43 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $220 | $135.73 | n/a | 1 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $526.74 | n/a | 1 | Sep 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $75.40 | n/a | 1 | Apr 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4.5 → $3.6 | $3.57 | n/a | 16 | Jul 27, 2018 |
Acadia Healthcare Company
Jul 13, 2026
Maintained: Hold
Price Target: $27 → $31
Current: $31.28
Upside: -0.90%
Charles River Laboratories International
Jul 13, 2026
Maintained: Hold
Price Target: $192 → $230
Current: $233.41
Upside: -1.46%
CVS Health
Jul 13, 2026
Maintained: Buy
Price Target: $115 → $120
Current: $104.15
Upside: +15.22%
Molina Healthcare
Jul 13, 2026
Maintained: Buy
Price Target: $215 → $255
Current: $233.31
Upside: +9.30%
UnitedHealth Group
Jul 13, 2026
Maintained: Buy
Price Target: $460 → $470
Current: $424.62
Upside: +10.69%
IQVIA Holdings
Jul 13, 2026
Maintained: Buy
Price Target: $215 → $230
Current: $207.85
Upside: +10.66%
Medpace Holdings
Jul 13, 2026
Maintained: Buy
Price Target: $495 → $586
Current: $538.23
Upside: +8.88%
ICON Public Limited Company
Jun 26, 2026
Maintained: Buy
Price Target: $180 → $190
Current: $167.72
Upside: +13.28%
Centene
Jun 8, 2026
Maintained: Hold
Price Target: $58 → $63
Current: $67.35
Upside: -6.46%
The Cigna Group
Jun 8, 2026
Maintained: Buy
Price Target: $330 → $340
Current: $293.46
Upside: +15.86%
Jun 8, 2026
Maintained: Buy
Price Target: $335 → $390
Current: $392.22
Upside: -0.57%
Jun 8, 2026
Maintained: Buy
Price Target: $435 → $465
Current: $416.23
Upside: +11.72%
May 12, 2026
Maintained: Hold
Price Target: $11 → $13
Current: $17.76
Upside: -26.80%
May 8, 2026
Maintained: Hold
Price Target: $18 → $24
Current: $26.27
Upside: -8.64%
May 8, 2026
Maintained: Buy
Price Target: $28 → $30
Current: $31.55
Upside: -4.91%
May 5, 2026
Maintained: Buy
Price Target: $52 → $61
Current: $71.43
Upside: -14.60%
Apr 29, 2026
Maintained: Buy
Price Target: $267 → $230
Current: $155.57
Upside: +47.84%
Mar 12, 2026
Maintained: Buy
Price Target: $235 → $265
Current: $204.25
Upside: +29.74%
Mar 5, 2026
Maintained: Buy
Price Target: $19 → $17
Current: $16.40
Upside: +3.66%
Feb 25, 2026
Maintained: Buy
Price Target: $540 → $585
Current: $406.59
Upside: +43.88%
Feb 18, 2026
Reiterated: Buy
Price Target: $320
Current: $276.81
Upside: +15.60%
Feb 12, 2026
Maintained: Buy
Price Target: $235
Current: $207.44
Upside: +13.29%
Feb 9, 2026
Reiterated: Buy
Price Target: $134
Current: $110.16
Upside: +21.64%
Dec 18, 2025
Maintained: Buy
Price Target: $13 → $12
Current: $10.08
Upside: +19.05%
Mar 7, 2025
Maintained: Buy
Price Target: n/a
Current: $303.44
Upside: n/a
Nov 6, 2024
Maintained: Hold
Price Target: n/a
Current: $805.96
Upside: n/a
Nov 4, 2024
Rated: Hold
Price Target: $110
Current: $235.80
Upside: n/a
Nov 8, 2022
Maintained: Hold
Price Target: $220
Current: $135.73
Upside: n/a
Sep 12, 2022
Reiterated: Buy
Price Target: n/a
Current: $526.74
Upside: n/a
Apr 11, 2022
Reiterated: Buy
Price Target: n/a
Current: $75.40
Upside: n/a
Jul 27, 2018
Reiterated: Hold
Price Target: $4.5 → $3.6
Current: $3.57
Upside: n/a